www.黄片视频在线播放,欧美精品日韩精品一级黄,成年男女免费视频网站,99久久久国产精品免费牛牛四川,99久久精品国产9999高清,乱人妻中文字幕视频4399,亚洲男人在线视频观看

Y ѹӢժ > Ĵȫ > Y >

ݔѪt(y)WgZhZձ

l(f)rg:2020-10-22 Դ: Y c

hZ ݔѪt(y)WgZձ

ꑣ ȵأ



_ T A

ABO blood group determination ABO ѪͶ ABO Ѫͷ ABO ѪͶ ABOѪʹ_ absorption and elution test շɢԇ _ԇ շɢԇ ጳyԇ acute hypervolemic hemodilution; AHH ԸѪҺϡ ԸѪѪҺϡ ԸѪҺϡ ԸѪѪҺϡ acute normovolemic hemodilution; ANH ԵѪҺϡ ԵѪѪҺϡ ԵѪҺϡ ԵѪҺϡ adverse event ¼ ¼ ¼ ¹ allelic resolution typing λˮƽ o λˮƽ ˮƽ alloimmunization ͬNw w w w altruistic blood donation ԫIѪ ԾѪ ԾѪ ԾѪ antibody screening wY wYz wYz wYz apheresis blood component βѪҺɷ xgѪҺɷ ΒѪҺɷ ɷѪѪҺɷ Apheresis β xg Β ɷݾѪ audit criteria ˜ʄt ˘˜ ˜ʄt ˜ʄt autologous transfusion wݔѪ wѪ wݔѪ Ѫ B

blood cold chain ѪҺ ѪҺ ѪҺ ѪҺ blood donation adverse reaction IѪ Ѫ Ѫ Ѫ blood donation times per thousand population ǧ˿ګIѪ˴ ÿǧ˿ھѪ˴ ǧ˿ھѪ˴ ǧ˿ھѪ˴ blood donation IѪ Ѫ Ѫ Ѫ blood donor IѪ Ѫ Ѫ Ѫ߻ʿ blood establishment computer system ѪվϢϵy(tng) ѪCYӍϵy(tng) ѪҺYӍϵy(tng) ѪXϵy(tng) blood group typing Ѫb Ѫͷ Ѫb Ѫͷ blood quality ѪҺ| ѪҺƷ| ѪҺ| ѪҺ| blood screening test ѪҺYԇ ѪҺYzԇ ѪҺYz ѪҺYzyԇ blood-borne occupational exposure ѪԴšI(y)¶ ѪҺȾԼšI(y)¶ ѪԴšI(y)¶ ѪԴšI(y)| blood-donor care IѪo Ѫo ѪPo Ѫʿo C

cell grouping cell salvage Ѫ ѪҺ Ѫ clinical transfusion medicine RݔѪW RݔѪt(y)W RݔѪt(y)W RݔѪt(y)W closed system ]ϵy(tng) ]ϵy(tng) ]ϵy(tng) ܷϵy(tng) compatibility test ԇ ԇ ԙz Ԝyԇ complement-dependent lymphocytotoxicity test; CDC awهԼԇ awهܰ򶾚ԇ awهԼԇ awهܰͼyԇ complication related to blood donation IѪPl(f)Y ѪPl(f)Y ѪPl(f)Y ѪPl(f)Y confirmatory test _Cԇ _Jԇ _Cz _Jyԇ copper sulfate method ~ ~ ~ ~yԇ corrected count increment; CCI ѪСӋУֵ ѪСӋУӔ ݔעѪСָ Уָ crossmatch Ѫ Ѫ Ѫ Ѫ D

department of transfusion medicine t(y)ԺݔѪ ݔѪt(y)W t(y)ԺݔѪ o diversion pouch ·Dƴ ӱռ ӱռ donor (informed) consent IѪ֪ͬ Ѫ֪ͬ Ѫ֪ͬ Ѫʿ@֪ͬ donor deferral IѪ ѪѪ Ѫ Ѫ donor identification IѪߴ_J Ѫ˴_J Ѫݴ_J Ѫʿݴ_J donor quarantine IѪ Ѫ˸x o Ѫʿx donor reentry IѪߚw Ѫپ ѪپѪ ѪʿپѪ donor IѪ Ѫ Ѫ Ѫ E

electronic crossmatch ӽѪ ӽѪ ӽѪ XѪ elite controller Ӣ Ӣ o o emerging infection °l(f)Ⱦ °l(f)Ⱦ °l(f)Ⱦ °l(f)Ⱦ event ¼ ¼ ¼ ¼¹ external quality assessment; EQA g|ur ⲿƷ|u ⲿ|ur |u F

febrile non-hemolytic transfusion reaction; FNHTR Ѫ԰l(f)ᷴ Ѫ԰l(f) Ѫ԰l(f)ᷴ Ѫ԰l(f) first-time donor ΫIѪ ξѪ ״ξѪ ξѪ߻״ξѪ

forward type o freezing ك ٱ fundamental

transfusion

medicine AݔѪW AݔѪt(y)W AݔѪt(y)W AݔѪt(y)W G

grey zone ҅^(q) o ҅^(q) ɫ؎ H

haemovigilance; HV ѪҺȫO(jin)y ѪҺȫO(jin)y ѪҺAϵy(tng) ѪҺȫAϵy(tng) hematocrit; Hct t Ѫ t o hematology analyzer method ѪҺxzy ѪҺxzy ѪҺxzy ѪҺx Hemoglobin; Hb Ѫt Ѫt Ѫt ѪtػѪt hemoglobin test strip colorimetric assay Ѫtԇlɫ Ѫtԇlɫ Ѫtԇlɫ o high resolution typing ߷ֱʷ ߽ȷ ߷ֱʷ ߽ histocompatibility matching M M䌦 M M human leucocyte antigen; HLA ׼ԭ Ѫԭ ׼ԭ Ѫԭ I

immediate hemolytic transfusion reaction; IHTR ٰl(f)ѪݔѪ l(f)ѪݔѪ ѪݔѪ ѪݔѪ incidence rate ¸Ⱦ l(f) ¸Ⱦ l(f) initial test ԇ ԇ Ιz yԇ inter-instrument comparison xgȌ xgȌ xgȌ x֮g^ inter-laboratory comparison gȌ gȌ gȌ ֮g^ internal audit Ȳ| Ȳ Ȳ| Ȳ internal quality control; IQC ҃| ҃Ʒ Ȳ| ȲƷ| inter-reagent comparison ԇȌ ԇȌ ԇȌ ԇ֮g^ inter-regional donor quarantine ^(q)“ o o o inventory management ѪҺ ѪҺ irradiation ݗ

ݗ(չ)

ݗ ݗ L

laboratory information management system Ϣϵy(tng) YӍϵy(tng) YӍϵy(tng) YӍϵy(tng)

leukocyte reduction ȥ׼ p ȥ׼ ȥѪѪ Look back low resolution typing ͷֱʷ ͽȶ ͷֱʷ o lymphocyte microcytotoxicity test; LCT ΢ܰͼԇ ΢ܰ򶾚ԇ ΢ܰͼԇ o M

major crossmatch ȽѪ 󽻲 ȽѪ ҪѪ management review u 팏 u u minor crossmatch ΂ȽѪ С ΂ȽѪ ҪѪ mixed lymphocyte culture; MLC ܰͼB(yng) ܰB(yng) ܰͼB(yng) o mixed lymphocyte reaction; MLR ܰͼ ܰϷ ܰͼ o N

natural antibody Ȼw Ȼw Ȼw Ȼw naturally occurring antibody Ȼw Ȼaw ȻaĿw Ȼaw near miss ¼ Eeʧ Uʧ¼ o non-reactive o o o o non-remunerated voluntary blood donor ԸoIѪ oѪ oѪ oѪ nucleic acid testing yield; NAT yield zy z o yԇ O

occult HBV infection; OBI [͸ײȾ [ B ͸ײȾ [͸ײȾ [͸ one-way mixed lymphocyte culture ܰͼB(yng) ܰB(yng) ܰͼB(yng) o P

panel cells V M V o panel reactive antibody; PRA wV Mw wV o para-Bombay phenotype I IѪ I o pathogen inactivation; PI ԭw ԭ ԭw ԭ pathogen reduction; PR ԭwȥ ԭp ԭwȥ ԭ patient blood management; PBM ѪҺ ѪҺ ѪҺ Ѫ plasma exchange Ѫ{ÓQ Ѫ{ÓQ Ѫ{ÓQ QѪ{ platelet count; PLT ѪСӋ ѪСӋ ѪСӋ ѪС唵

platelet-rich plasma method ѪСѪ{ ѪСѪ{ ѪСѪ{ preoperative autologous blood donation; PAD gǰwѪ gǰwѪ gǰwѪ gǰѪ pretransfusion testing ݔѪǰzy ݔѪǰz ݔѪǰz ݔѪǰz prevalence rate ʢ proficiency testing; PT C ԇ C yԇ Q

quality objective |Ŀ Ʒ|Ŀ |Ŀ |Ŀ quality assurance |C Ʒ|C |C |^ quality control | Ʒ| | | R

reactive recalcification of plasma Ѫ{} Ѫ{} Ѫ{} Ѫ{} recipient (informed) consent Ѫ֪ͬ Ѫ֪ͬ Ѫ֪ͬ Ѫ߫@֪ͬ recipient identification Ѫߴ_J Ѫߴ_J Ѫݴ_J Ѫݴ_J red cell group system tѪϵy(tng) tѪѪϵy(tng) tѪϵy(tng) tѪϵy(tng) red cell reagent panel ԇtM tѪԇM ԇtM o regular donor ګIѪ ھѪ Ҏ(gu)Ѫ aѪ߻ھѪ repeat donor ؏ͫIѪ }Ѫ }Ѫ }Ѫ residual risk LU NLU NLU NLU reverse type o RhD initial typing RhD Ѫͳz RhD z RhD Ѫͳz RhD z RhD typing RhD Ѫb RhD RhD Ѫb RhD Ѫ͙z confirmatory test

for

Rh

negative Rh Դ_J

Rh Դ_J

Rh Դ_J Rh Դ_Jyԇ risk behavior LUО LUО ΣО LUΣО S

science of blood donation service IѪՌW ѪՌW ѪՌW ѪտƌW seroconversion ѪDQ ѪD ѪD ѪDQ serum grouping Ѫ嶨 Ѫ Ѫ嶨 o shelf life ڻЧ solid phase HLA antibody detection HLA wYxg HLA wzyg HLA wYxo

technology g standard operation procedure; SOP ˜ʲҎ(gu) ˜ʲ ˜ʲ ˜ʲ sterile welding o۽ o۽ o۽ o T

therapeutic apheresis ίԆβ ίԷxg ίԆΒ o therapeutic dose ί ί ί o traceability of blood component ѪҺɷֿ׷ۙ ѪҺɷ֮׷ ѪҺɷֿ׷ ׷ۙѪҺɷ transfusion complications ݔѪl(f)Y ݔѪl(f)Y ݔѪl(f)Y ݔѪaFāl(f)Y transfusion management ݔѪW ݔѪ ݔѪ ݔѪ transfusion reactions ݔѪ ݔѪ ݔѪ ݔѪaFķ transfusion technology ݔѪgW ݔѪg ݔѪgW ݔѪg transfusion-associated circulation overload; TACO ݔѪPѭh(hun)ؓ ݔѪPѭh(hun)d ݔѪPѭh(hun)ؓ o transfusion-free medicine oݔѪt(y)W ݔѪt(y) ݔѪt(y)W ݔѪt(y)W transfusion-transmissible infection ɽݔѪĸȾ ɽݔѪĸȾ ɽݔѪĸȾ ͸^ݔѪȾĂȾ transfusion-transmitted bacterial infection; TTBI ݔѪļȾ ݔѪļȾ ݔѪļȾ ͸^ݔѪȾļȾ transfusion-transmitted infection; TTI ݔѪȾ ݔѪĸȾ ݔѪȾ ͸^ݔѪȾĂȾ U

unexpected antibody identification ⿹wb Ҏ(gu)t(A)wYz twwa o unexpected antibody screening ⿹wY Ҏ(gu)t(A)wYz twwYz o V

validation of blood establishment computer system ѪվϢϵy(tng)_J ѪCYӍϵy(tng)C ѪҺYӍϵy(tng)_J ѪҺXϵy(tng)Ч_J validation _J C _J Ч_J W

window period մ մ մ

P~hZ ݔѪ gZ

cx

ѹӢժ www.91mayou.com